Valerio Therapeutics Société anonyme (EPA:ALVIO)
0.3945
-0.0065 (-1.62%)
Oct 22, 2026, 5:35 PM CEST
EPA:ALVIO Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -7.05 | -4.9 | -23.93 | -20.34 | -19.56 | -5.94 |
Depreciation & Amortization | 4.75 | 4.43 | 12.98 | 0.48 | 0.53 | 0.6 |
Loss (Gain) From Sale of Assets | 0.08 | - | -0.79 | - | - | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.21 | -0.18 |
Stock-Based Compensation | 0.02 | 0.07 | 0.39 | 0.51 | 0.72 | 0.22 |
Other Operating Activities | 0.89 | 1.04 | 2.98 | 2.63 | 1.78 | 0.86 |
Change in Other Net Operating Assets | 4.89 | 1.19 | -4.09 | -0.67 | 6.88 | -4.14 |
Operating Cash Flow | 3.58 | 1.84 | -12.46 | -17.39 | -9.44 | -8.57 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.71 | -1.32 | -0.32 | -0.18 | -0.49 | -0.14 |
Divestitures | - | - | -1.08 | - | - | - |
Investment in Securities | 0.01 | 0.15 | 0.01 | 0.01 | 0.08 | 0.07 |
Other Investing Activities | - | - | 0 | -0 | -0 | - |
Investing Cash Flow | -1.71 | -1.16 | -1.39 | -0.18 | -0.41 | -0.07 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | - | 3.11 |
Total Debt Issued | -3.86 | - | - | - | - | 3.11 |
Long-Term Debt Repaid | - | -0.81 | -1.36 | -1.23 | -1.51 | -0.49 |
Lease Payments | -0.41 | -0.41 | -0.36 | -0.34 | -0.41 | -0.49 |
Net Debt Issued (Repaid) | -3.7 | -0.81 | -1.36 | -1.23 | -1.51 | 2.62 |
Issuance of Common Stock | 0.04 | 0.04 | 0.02 | 12.14 | 7.97 | 9.35 |
Repurchase of Common Stock | - | - | - | -0.13 | - | - |
Other Financing Activities | -0.19 | 0 | 5.54 | -0.03 | 0 | 0 |
Financing Cash Flow | -3.85 | -0.77 | 4.21 | 10.76 | 6.46 | 11.98 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0 | -0 | -0.12 | 0.24 | 0.09 | 0.03 |
Miscellaneous Cash Flow Adjustments | 0 | - | 4.09 | -1.21 | 0 | - |
Net Cash Flow | -1.98 | -0.1 | -5.66 | -7.77 | -3.3 | 3.36 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.86 | 0.52 | -12.78 | -17.57 | -9.93 | -8.71 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 33.56% | 20.25% | -712.72% | -976.33% | -688.22% | -214.45% |
Free Cash Flow Per Share | 0.00 | 0.00 | -0.08 | -0.13 | -0.09 | -0.10 |
Levered Free Cash Flow | 2.39 | -0.74 | 5.77 | -9.79 | -2.92 | -7.36 |
Unlevered Free Cash Flow | 2.55 | -0.56 | 5.77 | -9.7 | -1.55 | -6.83 |
Free Cash Flow After Leases | 1.46 | 0.11 | -13.14 | -17.91 | -10.34 | -9.2 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | 4.89 | 1.19 | -4.09 | -0.67 | 6.88 | -4.14 |